Publicacións en colaboración con investigadores/as de Universitat de Barcelona (38)

2024

  1. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 23-32

  2. Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort

    Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 3, pp. 192-195

2023

  1. Addressing the unmet needs in patients with type 2 inflammatory diseases: when quality of life can make a difference

    Frontiers in Allergy, Vol. 4

  2. Disposition of Work-Related Asthma in a Spanish Asthma Cohort: Comparison of Asthma Severity Between Employed and Retired Workers

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 11, pp. 3407-3413.e1

  3. Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 281-288

  4. Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases

    Frontiers in immunology, Vol. 14, pp. 1310211

  5. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  6. Lung Function Abnormalities and Their Correlation With Clinical Characteristics and Inflammatory Markers in Adult Asthma

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 294-296

  7. The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 608-611

2022

  1. Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 3, pp. 863-866.e1

  2. How reliably can algorithms identify eosinophilic asthma phenotypes using non-invasive biomarkers?

    Clinical and Translational Allergy, Vol. 12, Núm. 8

  3. Safety of COVID-19 vaccination in patients with clonal mast cell disorders

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 5, pp. 1374-1376.e3

2021

  1. Chronic toxicity and long-term outcome in intraoperative electron radiotherapy as boost followed by whole-breast irradiation

    Clinical and Translational Oncology, Vol. 23, Núm. 8, pp. 1593-1600

2020

  1. Author Correction: Validating a breast cancer score in Spanish women. The MCC-Spain study (Scientific Reports, (2018), 8, 1, (3036), 10.1038/s41598-018-20832-0)

    Scientific Reports

  2. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

    Clinical and Translational Allergy

  3. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air® App

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 7, pp. 1672-1688

2019

  1. A Simple Score for Future Risk Prediction in Patients with Controlled Asthma Who Undergo a Guidelines-Based Step-Down Strategy

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 4, pp. 1214-1221.e3

  2. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 3, pp. 864-879

  3. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

    Clinical and Translational Allergy, Vol. 9, Núm. 1

  4. MASK (Mobile Airways Sentinel Network), a mobile App with ARIA’s comprehensive solution in Spanish-speaking countries

    Revista Alergia Mexico, Vol. 66, Núm. 2, pp. 263-268